Foghorn Therapeutics Inc.’s FHTX share price has surged by 15.29%, which has investors questioning if this is right time to ...

CAMBRIDGE, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Foghorn ® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious ...

Foghorn Therapeutics Inc. (FHTX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings ...

The SF Giants published their non-roster list on Friday with pitchers and catchers reporting next week. A pair of top ...

One of the most iconic Looney Tunes characters, Foghorn Leghorn, has become the star of his own meme on Twitter / X. The meme features Foghorn Leghorn rambling to anime characters in his signature ...

B. Riley initiated coverage of Foghorn Therapeutics (FHTX) with a Buy rating and $10 price target. The firm says its investment thesis centers ...

How did the SF Giants do this offseason? Jake Mintz and Jordan Shusterman of Yahoo Sports handed out offseason grades and ...

We've been pushing the state of the art on how you do AI and machine learning on high-velocity data,' FogHorn CEO David King tells CRN about the startup's edge intelligence capabilities.

B. Riley initiates Foghorn Therapeutics at buy with $10 price target, citing promising development of SMARCA2 inhibitors for ...

Equities researchers at B. Riley issued their FY2024 earnings per share (EPS) estimates for shares of Foghorn Therapeutics in a report released on Wednesday, January 29th. B. Riley analyst K. Patel ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Foghorn Therapeutics (FHTX) has received a new Buy rating, initiated by B.Riley Financial analyst, Kalpit Patel.Invest with Confidence: Follow ...